Suzie J Otto

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. ncbi request reprint Effective PSA contamination in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer
    Suzie J Otto
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Int J Cancer 105:394-9. 2003
  2. doi request reprint Mammography screening and risk of breast cancer death: a population-based case-control study
    Suzie J Otto
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, P O Box 2040, Rotterdam 3000 CA, The Netherlands
    Cancer Epidemiol Biomarkers Prev 21:66-73. 2012
  3. doi request reprint PSA levels and cancer detection rate by centre in the European Randomized Study of Screening for Prostate Cancer
    S J Otto
    Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, P O Box 2040, 3000 CA Rotterdam, The Netherlands
    Eur J Cancer 46:3053-60. 2010
  4. doi request reprint Blinded and uniform causes of death verification in cancer screening: a major influence on the outcome of a prostate cancer screening trial?
    S J Otto
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Eur J Cancer 46:3061-7. 2010
  5. ncbi request reprint Risk of cardiovascular mortality in prostate cancer patients in the Rotterdam randomized screening trial
    Suzie J Otto
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    J Clin Oncol 24:4184-9. 2006
  6. ncbi request reprint Low all-cause mortality in the volunteer-based Rotterdam section of the European randomised study of screening for prostate cancer: self-selection bias?
    S J Otto
    Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    J Med Screen 11:89-92. 2004
  7. ncbi request reprint Update on screening and early detection of prostate cancer
    Suzie J Otto
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Curr Opin Urol 14:151-6. 2004
  8. doi request reprint Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up
    Xiaoye Zhu
    Department of Urology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
    Eur Urol 60:330-6. 2011
  9. pmc Prostate-specific antigen screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer-Rotterdam
    Elisabeth M Wever
    Department of Public Health, Erasmus Medical Center, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    J Natl Cancer Inst 102:352-5. 2010
  10. ncbi request reprint Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer
    Gerrit Draisma
    Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
    J Natl Cancer Inst 95:868-78. 2003

Detail Information

Publications21

  1. ncbi request reprint Effective PSA contamination in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer
    Suzie J Otto
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Int J Cancer 105:394-9. 2003
    ..Although the reasons for ordering PSA test or indicating biopsy are unknown, effective PSA contamination in the Rotterdam ERSPC section is low and not likely to jeopardize the power of the trial...
  2. doi request reprint Mammography screening and risk of breast cancer death: a population-based case-control study
    Suzie J Otto
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, P O Box 2040, Rotterdam 3000 CA, The Netherlands
    Cancer Epidemiol Biomarkers Prev 21:66-73. 2012
    ..Using individual data of women invited to screening, we conducted a case-control study to assess the effectiveness of the Dutch population-based program of mammography screening...
  3. doi request reprint PSA levels and cancer detection rate by centre in the European Randomized Study of Screening for Prostate Cancer
    S J Otto
    Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, P O Box 2040, 3000 CA Rotterdam, The Netherlands
    Eur J Cancer 46:3053-60. 2010
    ..To describe the variation in PSA level by age group and screening round in the ERSPC centres and the variation in cancer detection rates in relation to the underlying prostate cancer incidence...
  4. doi request reprint Blinded and uniform causes of death verification in cancer screening: a major influence on the outcome of a prostate cancer screening trial?
    S J Otto
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Eur J Cancer 46:3061-7. 2010
    ....
  5. ncbi request reprint Risk of cardiovascular mortality in prostate cancer patients in the Rotterdam randomized screening trial
    Suzie J Otto
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    J Clin Oncol 24:4184-9. 2006
    ....
  6. ncbi request reprint Low all-cause mortality in the volunteer-based Rotterdam section of the European randomised study of screening for prostate cancer: self-selection bias?
    S J Otto
    Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    J Med Screen 11:89-92. 2004
    ..In addition, the accuracy of the randomisation was evaluated by comparison amongst the trial arms...
  7. ncbi request reprint Update on screening and early detection of prostate cancer
    Suzie J Otto
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Curr Opin Urol 14:151-6. 2004
    ..The aim of this review is to discuss advances in the field of screening and early detection of prostate cancer from papers published in 2003...
  8. doi request reprint Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up
    Xiaoye Zhu
    Department of Urology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
    Eur Urol 60:330-6. 2011
    ..In a screening program, interval cancers are cancers diagnosed between two screening visits...
  9. pmc Prostate-specific antigen screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer-Rotterdam
    Elisabeth M Wever
    Department of Public Health, Erasmus Medical Center, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    J Natl Cancer Inst 102:352-5. 2010
    ..26 in the United States vs 0.94 in ERSPC-Rotterdam. We conclude that the efficacy of PSA screening in detecting prostate cancer was lower in the United States than in ERSPC-Rotterdam...
  10. ncbi request reprint Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer
    Gerrit Draisma
    Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
    J Natl Cancer Inst 95:868-78. 2003
    ..Both consequences have considerable impact on the net benefits of screening...
  11. doi request reprint Screening for prostate cancer: results of the Rotterdam section of the European randomized study of screening for prostate cancer
    Monique J Roobol
    Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands
    Eur Urol 64:530-9. 2013
    ..Evidence from randomized trials on the effects of screening for prostate cancer (PCa) on disease-specific mortality accumulates slowly with increasing follow-up...
  12. ncbi request reprint Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review
    Suzie J Otto
    Department of Public Health, Erasmus MC, University Medical Centre, Rotterdam, Netherlands
    Lancet 361:1411-7. 2003
    ..More than a decade ago, a mammography screening programme for women aged 50-69 years was initiated in the Netherlands. Our aim was to assess the effect of this programme on breast-cancer mortality rates...
  13. doi request reprint Increased non-prostate cancer death risk in clinically diagnosed prostate cancer
    Pim J van Leeuwen
    Department of Urology Public Health, Erasmus Medical Centre, Rotterdam Cancer Registry Rotterdam, Rotterdam, The Netherlands
    BJU Int 110:188-94. 2012
    ..Men with clinically diagnosed PC have an increased risk of death unrelated to PC itself, i.e., the excess mortality is based on an increased risk of dying from other neoplasm and diseases of the circulatory or respiratory system...
  14. pmc Screening for type 2 diabetes in a high-risk population: study design and feasibility of a population-based randomized controlled trial
    Bart Klijs
    Department of Public Health, Erasmus MC, PO Box 2040, 3000 CA Rotterdam, Netherlands
    BMC Public Health 12:671. 2012
    ..We describe the design and present the results of the first year of a population-based study of screening for type 2 diabetes in individuals at high risk of developing the disease. High risk is defined as having abdominal obesity...
  15. ncbi request reprint Feasibility study of adjustment for contamination and non-compliance in a prostate cancer screening trial
    Stijn Roemeling
    Department of Urology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
    Prostate 67:1053-60. 2007
    ..We present a feasibility study and impact simulation of a secondary analysis, which imitates a situation where all participants in the study are managed according to their random assignment...
  16. ncbi request reprint Overall survival in the intervention arm of a randomized controlled screening trial for prostate cancer compared with a clinically diagnosed cohort
    Andre N Vis
    Department of Urology, Erasmus Medical Center, Rotterdam, The Netherlands
    Eur Urol 53:91-8. 2008
    ..Overall survival in both cohorts was compared with that in the general population...
  17. doi request reprint Quality-of-life effects of prostate-specific antigen screening
    Eveline A M Heijnsdijk
    Department of Public Health, Erasmus Medical Center, P O Box 2040, 3000 CA Rotterdam, The Netherlands
    N Engl J Med 367:595-605. 2012
    ..However, the extent to which harms to quality of life resulting from overdiagnosis and treatment counterbalance this benefit is uncertain...
  18. doi request reprint Screening for type 2 diabetes in a high-risk population: effects of a negative screening test after 4 years follow-up
    Julie I Willems
    Department of Public Health, Erasmus MC, P O Box 2040, 3000 CA, Rotterdam, Netherlands
    Ann Behav Med 47:102-10. 2014
    ..A negative diabetes screening test may unintentionally provide reassurance, resulting in reduced incentive to follow a healthy lifestyle...
  19. ncbi request reprint Limited contamination in the Dutch-Belgian randomized lung cancer screening trial (NELSON)
    Eleonora Baecke
    Department of Public Health, Erasmus MC University Medical Center Rotterdam, P O Box 2040, 3000 CA Rotterdam, The Netherlands
    Lung Cancer 69:66-70. 2010
    ..In conclusion, the rate of contamination among male subjects of the control arm of the NELSON trial is low and is not likely to jeopardize the power of the trial...
  20. pmc Decreased rates of advanced breast cancer due to mammography screening in The Netherlands
    J Fracheboud
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 1753, NL 3000 DR Rotterdam, The Netherlands
    Br J Cancer 91:861-7. 2004
    ..It is evident that breast cancer screening contributes to a reduction in advanced breast cancers and breast cancer mortality...
  21. ncbi request reprint Impressive time-related influence of the Dutch screening programme on breast cancer incidence and mortality, 1975-2006
    Johannes D M Otten
    Department of Epidemiology, Biostatistics and Health Technology Assessment, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    Int J Cancer 123:1929-34. 2008
    ..The results indicate an impressive decrease in breast cancer mortality in the age group invited for breast cancer screening, starting to show quite soon after implementation...